The Saudi Food and Drug Authority (SFDA), headquartered in Riyadh, Saudi Arabia, plays a pivotal role in safeguarding public health through its comprehensive regulatory framework. Established in 2003, the SFDA oversees the food, drug, and medical device sectors, ensuring that products meet stringent safety and quality standards. With a focus on enhancing consumer protection, the SFDA is responsible for the registration and monitoring of pharmaceuticals, food products, and medical devices across the Kingdom. Its unique approach combines scientific research with regulatory oversight, positioning it as a leader in the region. Notable achievements include the implementation of advanced regulatory systems and initiatives aimed at promoting food safety and drug efficacy. The SFDA continues to strengthen its market position by fostering innovation and ensuring compliance with international standards, ultimately contributing to the health and well-being of the Saudi population.
How does Saudi Food and Drug Authority's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Saudi Food and Drug Authority's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
The Saudi Food and Drug Authority (SFDA) currently does not have available carbon emissions data, as indicated by the absence of specific figures for kg CO2e. Consequently, there are no reported Scope 1, 2, or 3 emissions or any significant reduction targets or achievements at this time. Furthermore, the SFDA has not outlined any specific climate commitments or initiatives aimed at reducing carbon emissions. As such, there are no details regarding any Science-Based Targets Initiative (SBTi) commitments or other climate pledges. In the context of climate action, the SFDA's current status reflects a need for enhanced transparency and commitment to sustainability practices, which are increasingly vital in the global effort to combat climate change.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Saudi Food and Drug Authority has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
